Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

The objective of this study was to assess survival trends in elderly patients with stage III colon cancer

Completed

Looking for future studies?

Key information

Conditions

Colon Adenocarcinoma Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Neoplasms Neoplasms by Site

Age range

80 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Registre de tumeurs digestives du Finistère

Brest, 29200, France

About this study

This retrospective population-based study included patients aged 80 years and older with stage III colon adenocarcinoma who underwent surgery between 2007 and 2014.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Stage 3 colon adenocarcinoma

Exclusion criteria

Rectal tumors
Patients receiving neo-adjuvant chemotherapy or radiotherapy
Tumours of the appendix
Tumours with histology other than adenocarcinoma

Treatment and study plan

Observational

Other

observational

Primary outcomes

Overall survival

Time frame: 2007-2014

months

Sponsors and collaborators

Lead sponsor

Registre des Tumeurs Digestives du Finistère

Other

Registry information

Important dates

Study start: 2018
Primary completion: 2020
Study completion: 2020
First posted: Aug 25, 2020
Registry last updated: Aug 25, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed